Sogol Baharlou

Sogol Baharlou currently serves as the Associate Director of Innovation and Translational Development at Fox Chase Cancer Center since January 2024. Prior to this role, Sogol held the position of Senior Manager, Strategic Partnerships at the Center for Breakthrough Medicines from May 2022 to July 2023, and earlier worked as a Senior Strategy Analyst at the same organization. From January 2018 to May 2022, Sogol was a Scientific Advisor at Riverside Law LLP. Sogol's experience also includes working as a Technology Analyst and Research Assistant at Temple University between August 2013 and December 2017, and serving as an Academic Coach at the Center for Learning and Student Success (CLASS). An internship at Echo Therapeutics occurred in July 2013, and prior experience includes a role as a Teacher Assistant at Temple University from February to June 2013. Sogol Baharlou earned a Doctor of Philosophy in Bioengineering and Biomedical Engineering from Temple University, completing the degree in November 2017.